Exact Sciences Corporation (EXAS) is an interesting player in the Healthcare space, with a focus on Medical Laboratories & Research. The stock has been active on the tape, currently trading at $42.36, up from yesterday’s close by 2.92%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Exact Sciences Corporation (EXAS) currently trades with a market capitalization of $5.48 Billion. That value represents a market adjusting for revenues that have been growing by 148.02 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$120.2 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.37 on a per share basis this quarter. Perhaps, that suggests something about why 3.17% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how EXAS has been acting. Looking at the stock’s movement on the chart, Exact Sciences Corporation recorded a 52-week high of $63.60. It is now trading 21.24% off that level. The stock is trading $46.26 its 50-day moving average by 3.9%. The stock carved out a 52-week low down at $22.46.
In recent action, Exact Sciences Corporation (EXAS) has made a move of -19.39% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.08, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 13.38% with $118.34 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of EXAS.